Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

638 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The oral disposition index calculated from a meal tolerance test is a crucial indicator for evaluating differential normalization of postprandial glucose and triglyceride excursions in morbidly obese patients after laparoscopic sleeve gastrectomy.
Yamamoto Y, Togawa T, Sekine O, Ozamoto Y, Fuse J, Azuma C, Ito-Kobayashi J, Oe Y, Hagiwara A, Kobayashi M, Kitamura T, Iwanishi M, Shimatsu A, Kashiwagi A. Yamamoto Y, et al. Among authors: kashiwagi a. Endocr J. 2023 Dec 28;70(12):1141-1157. doi: 10.1507/endocrj.EJ23-0241. Epub 2023 Oct 17. Endocr J. 2023. PMID: 37853621 Free article.
Effects of a new 75 g glucose- and high fat-containing cookie meal test on postprandial glucose and triglyceride excursions in morbidly obese patients.
Yamamoto Y, Ozamoto Y, Kobayashi M, Tezuka Y, Azuma C, Sekine O, Ito-Kobayashi J, Washiyama M, Oe Y, Iwanishi M, Togawa T, Hagiwara A, Kitamura T, Shimatsu A, Kashiwagi A. Yamamoto Y, et al. Among authors: kashiwagi a. Endocr J. 2022 Jun 28;69(6):689-703. doi: 10.1507/endocrj.EJ21-0615. Epub 2022 Jan 27. Endocr J. 2022. PMID: 35082201 Free article.
A newly developed glucagon sandwich ELISA is useful for more accurate glucagon evaluation than the currently used sandwich ELISA in subjects with elevated plasma proglucagon-derived peptide levels.
Kobayashi M, Maruyama N, Yamamoto Y, Togawa T, Ida T, Yoshida M, Miyazato M, Kitada M, Hayashi Y, Kashiwagi A, Kitamura T. Kobayashi M, et al. Among authors: kashiwagi a. J Diabetes Investig. 2023 May;14(5):648-658. doi: 10.1111/jdi.13986. Epub 2023 Feb 2. J Diabetes Investig. 2023. PMID: 36729958 Free PMC article.
A Prospective, Open-Label Short-Term Pilot Study on Modification of the Skin Hydration Status During Treatment With a Sodium-Glucose Cotransporter-2 Inhibitor.
Tezuka Y, Sekine O, Hirano A, Hanada Y, Nakanishi I, Ariga M, Azuma C, Yamamoto Y, Ito-Kobayashi J, Washiyama M, Iwanishi M, Furuta M, Kanamori M, Shimatsu A, Kashiwagi A. Tezuka Y, et al. Among authors: kashiwagi a. Diabetes Ther. 2021 Jan;12(1):431-440. doi: 10.1007/s13300-020-00950-7. Epub 2020 Oct 27. Diabetes Ther. 2021. PMID: 33108650 Free PMC article.
Ezetimibe prevents hepatic steatosis induced by a high-fat but not a high-fructose diet.
Ushio M, Nishio Y, Sekine O, Nagai Y, Maeno Y, Ugi S, Yoshizaki T, Morino K, Kume S, Kashiwagi A, Maegawa H. Ushio M, et al. Among authors: kashiwagi a. Am J Physiol Endocrinol Metab. 2013 Jul 15;305(2):E293-304. doi: 10.1152/ajpendo.00442.2012. Epub 2013 May 28. Am J Physiol Endocrinol Metab. 2013. PMID: 23715726 Free article.
638 results